𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Demonstration of a transient rheumatoid factor in the acute phase of hepatitis non A, non B

✍ Scribed by M. Roggendorf; F. Deinhardt; B. Böhm; E. Tabor

Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
616 KB
Volume
15
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The evaluation of an enzyme‐linked immunosorbent assay (ELISA) test designed to detect antigens of hepatitis non A, non B (HNANB) revealed that a rheumatoid factor (RF)‐like reaction was interfering. This RF‐like reaction was not detectable by routine screening methods for RF, such as latex agglutination or the Waaler Rose test. Testing of sequential sera of chimpanzees with acute HNANB showed that this RF‐like reaction was present in the acute phase of HNANB simultaneously with alanine aminotransferase (ALT) elevations. Characterization of this RF‐like reaction revealed the presence of an JgM antibody against human IgG that banded in CsCl at 1.3 g/ml and at 19S in sucrose gradients. Absorption with IgG‐coated latex particles and anti‐human IgM gave further evidence of an RF. By testing sera of patients with different forms of acute viral hepatitis, it was demonstrated that an RF‐like factor was also present in seven sera from 9 patients with acute hepatitis A, in two sera from 11 patients with hepatitis B, and seven sera from 11 patients with acute HNANB. The rise of RF in the acute phase of hepatitis A may be an effect of polyclonal stimulation of IgM producing B lymphocytes. The high prevalence of RF in HNANB remains unclear as no polyclonal stimulation of IgM has been observed.

📜 SIMILAR VOLUMES

Unrelatedness of factor VIII-derived non
Unrelatedness of factor VIII-derived non-A/non-B hepatitis and hepatitis B virus
✍ H. A. Fields; C. L. Davis; H. S. Margolis; K. A. McCaustland; C. M. Wheeler; J. 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB 👁 1 views

A DNA hybridization assay was used to detect hepatitis B virus (HBV)-specific DNA sequences in extracted sera obtained from chimpanzees infected with HBV, hepatitis A virus (HAV), and a factor VIII-derived non-A/non-B (NANB) agent. The results did not reveal any HBV-DNA homology with sera obtained f

Aetiology of acute sporadic non-A, non-B
Aetiology of acute sporadic non-A, non-B viral hepatitis in India
✍ Dr.(Mrs) V. A. Arankalle; L. P. Chobe; J. Jha; M. S. Chadha; K. Banerjee; M. O. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB 👁 1 views

## Abstract Non‐A, non‐B (NANB) hepatitis viruses are now classified as hepatitis E (enterically transmitted) and hepatitis C (parenterally transmitted). India experiences a large number of epidemics of the enteric disease every year. In addition, about 70% of the sporadic cases among adults are al

Rheumatoid factor-like reactants in sera
Rheumatoid factor-like reactants in sera proven to transmit non-A, non-B hepatitis: A potential source of false-positive reactions in non-A, non-B assays
✍ Hiroyuki Shiraishi; Harvey J. Alter; Stephen M. Feinstone; Robert H. Purcell 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 810 KB

Convalescent phase non-A, non-B (NANB) human and chimpanzee sera were utilized in a solidphase radioimmunoassay (RIA) in a n attempt to identify a specific NANB antigen in human plasma, plasma-derived pellets and NP-40 disrupted pellets proven to transmit NANB infection to chimpanzees. RIA reactivit

Etiological investigation of acute post-
Etiological investigation of acute post-transfusion non-A, non-B hepatitis in China
✍ Kang-Xian Luo; Zhi-Sen Liang; Shou-Chang Yang; Rong Zhou; Qing-Hua Meng; You-Wu 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

The etiology of acute post-transfusion hepatitis (PTH) non-A, non-B (NANB) in China was investigated with the combination of advanced techniques, including a second generation of enzyme immunoassay for detection of the antibodies to hepatitis C virus (anti-HCV), a reverse transcription and nested po

Effect of (+)-Cyanidanol-3 in Acute HAV,
Effect of (+)-Cyanidanol-3 in Acute HAV, HBV, and Non-A, Non-B Viral Hepatitis
✍ Marcello Piazza; Vincenzo Guadagnino; Ludovico Picciotto; Renato De Mercato; Ant 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB 👁 1 views

A double-blind trial was carried out on 124 randomized patients with acute viral hepatitis, of whom 58 were treated with (+)-cyanidanol-3 in a dose of 3 g m per day and 66 with placebo. The treatment was given for 50 days. At 5-day intervals, SGPT, SGOT, and total serum bilirubin levels were tested.